These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 3274825)
1. Specific destruction of allogeneic tumor cells in vivo by a bismuth-212 immunotoxin. Stuart FP; Perdrizet G; Steranka B; Buckingham M; Lopes D; Alvarez V; Rodwell J; McKearn T; Hines J; Atcher R Transplant Proc; 1987 Feb; 19(1 Pt 1):605-6. PubMed ID: 3274825 [No Abstract] [Full Text] [Related]
2. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688 [TBL] [Abstract][Full Text] [Related]
3. Genetically engineered monoclonal antibodies armed with radionuclides. Waldmann TA Year Immunol; 1993; 7():205-12. PubMed ID: 8103951 [No Abstract] [Full Text] [Related]
4. Treatment of murine lymphoma with anti-Thy-1.1 antibodies. Badger CC; Bernstein ID Immunol Ser; 1989; 45():515-29. PubMed ID: 2577327 [No Abstract] [Full Text] [Related]
5. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac. Hartmann F; Horak EM; Garmestani K; Wu C; Brechbiel MW; Kozak RW; Tso J; Kosteiny SA; Gansow OA; Nelson DL Cancer Res; 1994 Aug; 54(16):4362-70. PubMed ID: 8044783 [TBL] [Abstract][Full Text] [Related]
6. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody. Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098 [TBL] [Abstract][Full Text] [Related]
7. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi. Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of growth of human tumor xenografts in athymic mice treated with ricin toxin A chain-monoclonal antibody 791T/36 conjugates. Byers VS; Pimm MV; Scannon PJ; Pawluczyk I; Baldwin RW Cancer Res; 1987 Oct; 47(19):5042-6. PubMed ID: 3497715 [TBL] [Abstract][Full Text] [Related]
9. Anti-B4-blocked ricin immunotoxin shows therapeutic efficacy in four different SCID mouse tumor models. Shah SA; Halloran PM; Ferris CA; Levine BA; Bourret LA; Goldmacher VS; Blättler WA Cancer Res; 1993 Mar; 53(6):1360-7. PubMed ID: 7680284 [TBL] [Abstract][Full Text] [Related]
10. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors. Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356 [TBL] [Abstract][Full Text] [Related]
11. Recent therapeutic advances in hematological malignancies: the role of targeted therapies in lymphoma. Schmitz N Ann Oncol; 2008 Jul; 19 Suppl 5():v63-7. PubMed ID: 18611903 [No Abstract] [Full Text] [Related]
12. Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer. Senekowitsch-Schmidtke R; Schuhmacher C; Becker KF; Nikula TK; Seidl C; Becker I; Miederer M; Apostolidis C; Adam C; Huber R; Kremmer E; Fischer K; Schwaiger M Cancer Res; 2001 Apr; 61(7):2804-8. PubMed ID: 11306447 [TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma. Griffin TW; Richardson C; Houston LL; LePage D; Bogden A; Raso V Cancer Res; 1987 Aug; 47(16):4266-70. PubMed ID: 3496960 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies and immunoconjugates for cancer treatment. Baldwin RW; Byers VS; Pimm MV Cancer Chemother Biol Response Modif; 1988; 10():397-415. PubMed ID: 3079393 [No Abstract] [Full Text] [Related]
15. Medical applications of monoclonal antibodies. Clark MR Revis Biol Celular; 1986; 9():1-79. PubMed ID: 3324213 [TBL] [Abstract][Full Text] [Related]
16. Locoregional alpha-radioimmunotherapy of intraperitoneal tumor cell dissemination using a tumor-specific monoclonal antibody. Huber R; Seidl C; Schmid E; Seidenschwang S; Becker KF; Schuhmacher C; Apostolidis C; Nikula T; Kremmer E; Schwaiger M; Senekowitsch-Schmidtke R Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3922S-8S. PubMed ID: 14506190 [TBL] [Abstract][Full Text] [Related]
17. [Further results of radiobismuth therapy of infantile lymphoblastic leukemia]. Mussa GC; Martini Mauri M; Bacolla D; Madon E Minerva Pediatr; 1970 Feb; 22(6):289-95. PubMed ID: 5264509 [No Abstract] [Full Text] [Related]